Chargeurs (CRI) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
H1 2024 marked by strong operational rebound and acceleration, with all business lines ramping up and significant outperformance at Museum Studio.
Group revenue rose 11.1% like-for-like to €374.3m; recurring operating profit up nearly 34% to €17.0m.
Robust cash generation: €39.6m operating cashflow (x44 vs H1 2023), with strong contributions from Novacel, Chargeurs PCC, Luxury Fibers, and Museum Studio.
Shareholders' equity increased by €39.7m to nearly €300m; financial debt reduced by €32.4m.
Strategic plan for 2025-2030 in preparation; dividend payments expected to resume in 2025.
Financial highlights
Revenue: €374.3m (+11.1% like-for-like year-over-year).
EBITDA: €29.6m (+20.8% year-over-year); recurring operating profit: €17.0m (+33.9%).
Gross margin improved to 26.5% from 25.6% year-over-year.
Net income impacted by exceptional expenses (takeover costs, restructuring), resulting in a net loss of €3.4m vs. €1.9m profit in H1 2023.
Operating cashflow: €39.6m (x44 vs H1 2023); financial debt reduced by €32.4m.
Outlook and guidance
Focus for H2 2024 on improving profitability and cash generation across all business lines.
Continued sales momentum expected, especially in the USA and Asia, with emphasis on higher-margin products.
Integration of Cilander to drive new market opportunities for Chargeurs PCC.
2024 net income expected to be profitable, assuming a stable environment.
Dividend payments anticipated to resume in 2025.
Latest events from Chargeurs
- Novacel sale and strategic refocus boost financial flexibility and target €1bn NAV by 2030.CRI
Q4 202519 Mar 2026 - Strong growth, strategic transformation, and all resolutions passed amid market and regulatory risks.CRI
AGM 202523 Dec 2025 - Strong Q3 growth in new businesses and luxury brands, with a robust outlook for 2026.CRI
Q3 20255 Nov 2025 - Stable H1 2025 revenue and NAV growth, strong Museum Studio, Novacel sale under review.CRI
Q2 202510 Sep 2025 - Q3 2024 revenue up 11.2% year-over-year, led by Novacel and Museum Studio growth.CRI
Q3 202413 Jun 2025 - Q1 2024 revenue up 10% as Chargeurs accelerates growth in high-value, sustainable markets.CRI
Investor Presentation13 Jun 2025 - Museum Studio and Personal Goods fueled 5.6% Q1 2025 revenue growth amid global headwinds.CRI
Q1 20256 Jun 2025 - Double-digit revenue growth, profit recovery, and strategic transformation marked 2024.CRI
Q4 20245 Jun 2025